Skip to Main Content Menu Search Site

Leveraging Nature's genius to tackle urgent global challenges.

A Force of Nature

It takes a force of Nature – a passionate team – to leverage Nature’s genius.

Nature has the answers to the world’s big problems. Only a Force of Nature – an organization of passionate people driven by impatience, hope, and biologically-inspired engineering – can unlock those answers. By relentlessly focusing on human and planetary health, our teams are creating novel solutions in cancer, women’s health, brain health, aging, infectious disease, environmental sustainability, and beyond.

Home

The Wyss Effect

A cascade of innovation beyond our walls.

We combine the depth of academic science with the speed and flexibility of industry, turning groundbreaking discoveries into market-ready solutions. This unique model fuels what we call The Wyss Effect – a cascade of innovation that influences science, engineering, and technology far beyond our walls, accelerating progress for patients and the planet.

That’s the power of The Wyss Effect.

CogniXense for Rare Disease Drug Discovery
CogniXense for Rare Disease Drug Discovery

Unravel Biosciences has licensed a Wyss drug discovery platform technology to identify and create drugs to treat complex central nervous system disorders, starting with Rett syndrome.

Human Ovarian Organoids to Improve Women’s Health
Human Ovarian Organoids to Improve Women’s Health

Gameto is using the Wyss Institute’s fully human ovarian organoid technology to solve the global problem of rising infertility by making IVF safer, cheaper, and more accessible.

SPEAR: Ultrasensitive Protein Detection in Small Samples
SPEAR: Ultrasensitive Protein Detection in Small Samples

Spear Bio uses a DNA nanotechnology-driven approach developed at the Wyss Institute that allows the sensitive detection of protein biomarkers in small samples using standard instruments to create new research and diagnostic assays. An ultra-sensitive assay detecting neutralizing antibodies against SARS-CoV-2 will be the first to be commercialized.

  • Publications 0
  • Patents Filed 0
  • Licenses Supported 0
  • Startups Enabled 0

Collaboration at a Higher Level

Our scientists, engineers and clinicians, who come from Harvard's Schools of Medicine, Engineering, Arts & Sciences, and Design as well as 12 collaborating academic institutions and hospitals, work alongside staff with industrial experience in product development to engineer transformative solutions to some of the world’s greatest problems.

Want to know more?

Close menu